COVID-19 @ NIBIB

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is administering the RADx® Tech and Advanced Technology Platforms (ATP) programs. These programs are part of the NIH RADx® Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. In addition, NIBIB is supporting other technology development, imaging approaches, and digital platforms to address the pandemic.

Rapid Acceleration of Diagnostics (RADx®) Tech and ATP Programs

What is it?

The RADx® Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.

What's been done?

Summary data on proposals submitted to the RADx® Tech and ATP Programs.

What tests are being developed?

Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.

COVID-19 Research across NIBIB

COVID-19 Funded Grant Projects

Listing of COVID-19 related grants funded by NIBIB.

MRI of chest with arrows pointing to points on the lungs

Medical Imaging and Data Resource Center

Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about this resource.

Videos

View videos about RADx® Tech/ATP programs, interviews with the NIBIB Director and more.

Program Contacts

RADx® Tech/ATP programmatic or technical inquiries: info.radx@poctrn.org

All other RADx® Tech/ATP Applicants: RADxNIBIB@mail.nih.gov

SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov

All others: COVID19NIBIB@nih.gov

Related Resources

NIH COVID-19 website

Learn about clinical trials for treatments and vaccines at HHS Combat COVID

NIH COVID-19 Information for Applicants/Grantees

Media Inquiries: nibibpress@mail.nih.gov or 301-496-3500

About COVID-19

Research information from NIH | Español

Public health information from CDC

NIH staff guidance on coronavirus (NIH Only)

Related News

View All News

When it comes to darker skin, pulse oximeters fall short

Grantee News

July 12, 2022

Over the past two years, the pulse oximeter has become a crucial tool for tracking the health of COVID-19 patients. The small device clips onto a finger and measures the amount of oxygen in a patient's blood. But a growing body of evidence shows the device can be inaccurate when measuring oxygen levels in people with dark skin tones. A study published in JAMA Internal Medicine only adds to this concern. Source: NPR

Pulse oximeter performance among minority patient groups may lead to reduced delivery of supplemental oxygen

Science Highlights

July 11, 2022

Clinician applying a pulse oximeter to a patient with dark skin

Minority patient groups may receive less supplemental oxygen in the ICU due to inaccurate readings from pulse oximeters.

RADx® Initiative & COVID-19 Solutions

NIBIB in the News

June 30, 2022

The Council on Strategic Risks hosted a webinar on June 8 titled RADx® Initiative & COVID-19 Solutions: Bioengineering at Unprecedented Speed and Scale. This NIH RADx Initiative was critical in the shift from solely laboratory-based testing to the public-private partnership that enabled the production and accessibility of point-of-care and over-the-counter COVID-19 tests. Source: Council on Strategic Risks

NIH-funded project offers efficient approach when tracking SARS-CoV-2 variants

Press Releases

June 29, 2022

Researchers funded by NIH's RADx Tech program have developed a fast, cost-effective method to detect the circulation of SARS-CoV-2 variants. The team adopted a customizable genotyping approach to identify known variants and subvariants—an approach that can augment current surveillance.

New research shows value of at-home antigen tests in slowing spread of COVID-19